Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study

Critical Care Medicine

Volumn 39, Issue 11, 2011, Pages 2440-2446

  Makris, Demosthenes ^a   Manoulakas, Efstratios ^a   Komnos, Apostolos ^c   Papakrivou, Eleni ^a   Tzovaras, Nikolaos ^a   Hovas, Achilleas ^c   Zintzaras, Elias ^b,d   Zakynthinos, Epaminondas ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c GENERAL HOSPITAL OF LARISSA   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

critical care; mechanical ventilation; pneumonia; statin; survival

Indexed keywords

CREATINE KINASE; LIVER ENZYME; PRAVASTATIN;

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 80054947489     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318225742c     Document Type: Article

References (41)

1. Richards MJ, Edwards JR, Culver DH, et al: Nosocomial infections in medical ICUs in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887-892 (Pubitemid 29266004)
2. Agbaht K, Diaz E, Muñoz E, et al: Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med 2007; 35:2064-2070 (Pubitemid 47326442)
3. Depuydt P, Benoit D, Vogelaers D, et al: Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 2006; 32:1773-1781 (Pubitemid 44607365)
4. Combes A, Luyt CE, Fagon JY, et al: Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35:146-154 (Pubitemid 46035690)
5. Nguile-Makao M, Zahar JR, Français A, et al: Attributable mortality of ventilator-associated pneumonia: Respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010; 36:781-789
6. Bercault N, Boulain T: Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control study. Crit Care Med 2001; 29:2303-2309 (Pubitemid 34038163)
7. Leone M, Bourgoin A, Giuly E, et al: Influence on outcome of ventilator-associated pneumonia in multiple trauma patients with head trauma treated with selected digestive decontamination. Crit Care Med 2002; 30: 1741-1746 (Pubitemid 34879584)
8. Garnacho-Montero J, Ortiz-Leyba C, Jimé-nez-Jiménez FJ, et al: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36:1111-1118 (Pubitemid 36549630)
9. Lorente L, Lecuona M, Jiménez A, et al: Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 2007; 176:1079-1083 (Pubitemid 350223753)
10. Rello J, Soñora R, Jubert P, et al: Pneumonia in intubated patients: Role of respiratory airway care. Am J Respir Crit Care Med 1996; 154:111-115 (Pubitemid 26255775)
11. Kostadima E, Kaditis AG, Alexopoulos EI, et al: Early gastrostomy reduces the rate of ventilator-associated pneumonia in stroke or head injury patients. Eur Respir J 2005; 26: 106-111 (Pubitemid 40945938)
12. Girou E, Buu-Hoi A, Stephan F, et al: Airway colonisation in long-term mechanically ventilated patients. Effect of semi-recumbent position and continuous subglottic suctioning. Intensive Care Med 2004; 30:225-233 (Pubitemid 38253412)
13. Fessler MB, Young SK, Jeyaseelan S, et al: A role for hydroxy-methylgutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med 2005; 171:606-615 (Pubitemid 40365416)
14. Rezaie-Majd A, Maca T, Bucek RA, et al: Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2002; 22:1194-1199 (Pubitemid 34764873)
15. Stamatogiannis N, Makris D, Zakynthinos E: Statins in bacteremia, sepsis and pneumonia: Have we found the Holy Grail? Recent Pat Inflamm Allergy Drug Discov 2009; 10: 167-176
16. Tseng MY, Hutchinson PJ, Czosnyka M, et al: Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38:1545-1550 (Pubitemid 46684172)
17. Almog Y, Shefer A, Novack V, et al: Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110: 880-885 (Pubitemid 39096018)
18. Schmidt H, Hennen R, Keller A, et al: Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med 2006; 32:1248-1251 (Pubitemid 44232422)
19. Søyseth V, Brekke PH, Smith P, et al: Statin use is associated with reduced mortality in COPD. Eur Respir J 2007; 29:279-283 (Pubitemid 46237383)
20. Schlienger RG, Fedson DS, Jick SS, et al: Statins and the risk of pneumonia: A population-based, nested case-control study. Pharmacotherapy 2007; 27:325-32 (Pubitemid 46327900)
21. van de Garde EMW, Hak E, Souverein PC, et al: Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 2006; 61:957-961 (Pubitemid 44787165)
22. Majumdar SR, McAlister FA, Eurich DT, et al: Statins and outcomes in patients admitted to hospital with community acquired pneumonia: Population based prospective cohort study. BMJ 2006; 333:999
23. Mead R, Curnow R: Statistical Methods in Agriculture and Experimental Biology (Texts in Statistical Science). New York, Chapman and Hall, 1983, p 34
24. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829 (Pubitemid 15250137)
25. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710 (Pubitemid 26254283)
26. British Thoracic Society Bronchoscopy Guidelines Committee: British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001; 56(Suppl 1):i1-i21
27. American Thoracic Society: Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388
28. Rello J, Paiva JA, Baraibar J, et al: International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia. Chest 2001; 120:955-970 (Pubitemid 32888237)
29. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
30. Mortensen EM, Restrepo MI, Anzueto A, et al: The effect of prior statin use on 30-day mortality for patients hospitalized with community acquired pneumonia. Respir Res 2005; 25:82
31. Frost FJ, Petersen H, Tollestrup K, et al: Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007; 131:1006-1012 (Pubitemid 46608700)
32. Schmidt H, Hennen R, Keller A, et al: Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med 2006; 32:1248-1251 (Pubitemid 44232422)
33. Rosenson RS, Tangney CC, Casey LC: Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999; 353: 983-984 (Pubitemid 29132615)
34. Pleiner J, Schaller G, Mittermayer F, et al: Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 2004; 110: 3349-3354 (Pubitemid 39557498)
35. Lee TS, Chang CC, Zhu Y, Shyy JY: Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection. Circulation 2004; 110:1296-1302 (Pubitemid 39202348)
36. Jameson JM, Cruz J, Costanzo A, et al: A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes. Cell Immunol 2010; 264:71-77
37. Jerwood S, Cohen J: Unexpected antimicrobial effect of statins. J Antimicrob Chemother 2008; 61:362-364
38. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903 (Pubitemid 34774654)
39. Marquette CH, Georges H, Wallet F, et al: Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 1993; 148: 138-144 (Pubitemid 23187233)
40. Torres A, Aznar R, Gatell JM, et al: Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528 (Pubitemid 20292709)
41. Fagon JY, Chastre J, Vuagnat A, et al: Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866-869 (Pubitemid 26087224)